Recap: Lantern Pharma Q4 Earnings

Lantern Pharma (NASDAQ:LTRN) reported its Q4 earnings results on Monday, March 18, 2024 at 04:02 PM.

Here's what investors need to know about the announcement.

Lantern Pharma beat estimated earnings by 3.0%, reporting an EPS of $-0.39 versus an estimate of $-0.4.

Revenue was down $0 from the same period last year.

Last quarter the company beat on EPS by $0.16 which was followed by a 33.0% increase in the share price the next day.

To track all earnings releases for Lantern Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.